Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Cell Cycle
Cerebral Blood Volume
Globins
Lye
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018 May/Jun; 25(3):e394-e396.
View in:
PubMed
subject areas
Anilides
Antineoplastic Agents
Biphenyl Compounds
Carcinoma, Basal Cell
Humans
Male
Middle Aged
Pyridines
Skin Neoplasms
Smoothened Receptor
Treatment Outcome
authors with profiles
Sami Ibrahimi